about
Cognitive and environmental predictors of early literacy skillsDoes cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerismsCognitive impairment and decline in different MS subtypes.Hot and cool forms of inhibitory control and externalizing behavior in children of mothers who smoked during pregnancy: an exploratory studySocial-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO studyNeurocognitive outcome in tyrosinemia type 1 patients compared to healthy controlsPrenatal Reflective Functioning and Development of Aggression in Infancy: the Roles of Maternal Intrusiveness and Sensitivity.Executive function in early-treated phenylketonuria: profile and underlying mechanisms.Interrelations Between Maternal Smoking During Pregnancy, Birth Weight and Sociodemographic Factors in the Prediction of Early Cognitive AbilitiesCognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development.Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.White matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control.Key European guidelines for the diagnosis and management of patients with phenylketonuria.Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.Is BRIEF a useful instrument in day to day care of patients with phenylketonuria?The complete European guidelines on phenylketonuria: diagnosis and treatment.Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population.Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria.Negative affect is related to reduced differential neural responses to social and non-social stimuli in 5-to-8-month-old infants: A functional near-infrared spectroscopy-study.Parental Perceptions of Aggressive Behavior in Preschoolers: Inhibitory Control Moderates the Association With Negative Emotionality.Issues with European guidelines for phenylketonuria - Authors' reply.Infant Parasympathetic and Sympathetic Activity during Baseline, Stress and Recovery: Interactions with Prenatal Adversity Predict Physical Aggression in Toddlerhood.Neurological and Neuropsychological Problems in Tyrosinemia Type I Patients.Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.Interaction between prenatal risk and infant parasympathetic and sympathetic stress reactivity predicts early aggression.Neurocognitive moderation of associations between cannabis use and psychoneuroticism.Genetic disorders and neurobehavioural phenotypes.Maternal reflective functioning as a multidimensional construct: Differential associations with children's temperament and externalizing behavior.Cognitive control in adolescents with neurofibromatosis type 1.Prenatal reflective functioning in primiparous women with a high-risk profile.Infant autonomic nervous system response and recovery: Associations with maternal risk status and infant emotion regulation.Neurobiological and behavioral stress reactivity in children prenatally exposed to tobacco.Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria.
P50
Q34680583-DB467FDF-0F4D-4765-B412-E4FF5C406890Q35007679-09483073-9EF9-4FF8-BC41-D81A8E1BB3F5Q35109486-A8984A98-8E63-43A0-9940-BC8B60FCC0ADQ35814685-E8F742FC-CCFF-4AE4-B773-F9BB888F7C7FQ36165240-884220A6-E169-4EA7-ADF9-932C817BF895Q36462247-54520797-BA12-43D7-933B-622B73714554Q36498903-6AE893E8-8DF8-484A-9242-D4C32D35E0DEQ36853467-A1FA93C8-572F-4D9D-9105-F862C8063AF3Q37054911-3968C2DD-752B-4CA9-BE8C-5C4E6B2BAF08Q37590618-BC14205C-54EC-4FAF-A3C9-4FB405FEDBECQ37685636-F7360759-72BF-4702-BC7B-FA5950F88B43Q37725788-042B9D7D-27D3-4B29-97EC-D1199F9365CDQ37948373-8EBA4A4D-5E86-4224-A259-DE004ADD05CAQ38160972-1DC38651-BC6D-4D57-AC92-7AE5A0B32D74Q38759687-31261941-993A-4819-8287-6EA37091DE5DQ38802252-30F634B6-A2E4-4C02-A831-CDBAE3E23132Q39084317-8B77807E-BC63-4C06-8849-E38979CF9811Q41547697-C9BD2199-D014-427A-ABF9-69DC3E14CEF7Q41649228-D9A8A72B-CBA6-4FBF-8DE0-368AABA291C4Q42376686-C4149B0A-FC94-4F40-BCBC-D602D5E00005Q43177857-A4E84039-0A2B-4013-A03A-87EE22C3B341Q43973232-9434C329-04E0-49D1-B9C6-78D2CAAE9F17Q44284397-5002CA0D-3FD0-414C-9B00-1A8D35F40852Q44295266-70B1E56A-0890-469A-849A-57D60EE84CB2Q44575686-856C77D7-B995-495C-99B9-0CC57A4CD692Q47296674-39746AB0-2B9F-4D31-8170-876B3531EC46Q47625356-608E2C9F-2729-4B9E-92B1-A9F104C24F97Q47725655-9297FEA8-33D3-47AE-89F4-AA186B3B664BQ47752212-12A099C0-177B-4ABD-8DAD-4BBF6BE3E8C9Q47762401-10AD1FD2-33CC-4639-93D1-B09BCAC30A3FQ47772340-1976635F-7756-4BBB-9AB9-5B64B773D35CQ47829375-C52796C6-EB68-433A-B1B2-9F35B1425AE8Q47832638-F64DCC8F-5FCE-4A58-8AE8-7C19586880B0Q48143056-6314357B-A1E9-4822-85F3-7B9948169DB3Q48572252-F5BD65E0-599A-4E72-927C-2CF6C5B789BCQ48751923-4314208A-FB81-41FE-837A-CC6ED18149B5Q49110358-1F30CB89-0CFC-4B5F-86AA-C5EA4601D937Q50162077-EF5E0555-A610-4BAE-AE36-ACDA3885566EQ50647495-89388292-DFB2-4BA7-8C4C-783BCE892140Q50691782-267BA9AC-9C5B-4606-9836-A5F15039F7A6
P50
description
researcher ORCID ID = 0000-0002-7209-1912
@en
wetenschapper
@nl
name
Stephan C Huijbregts
@ast
Stephan C Huijbregts
@en
Stephan C Huijbregts
@es
Stephan C Huijbregts
@nl
type
label
Stephan C Huijbregts
@ast
Stephan C Huijbregts
@en
Stephan C Huijbregts
@es
Stephan C Huijbregts
@nl
prefLabel
Stephan C Huijbregts
@ast
Stephan C Huijbregts
@en
Stephan C Huijbregts
@es
Stephan C Huijbregts
@nl
P1153
7801631208
P31
P496
0000-0002-7209-1912